Industry News
Pharmaceutical Industry News
With Biden’s Agenda in the Balance, Lobbying Kicks Into High Gear
Business interests are using ads and other efforts to cajole Democrats to change or kill a $3.5 trillion social policy bill.
Study: Pfizer Vaccine Protects Against Hospitalization for Six Months
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
AstraZeneca underpaid hundreds of female and Hispanic sales reps, feds say
AstraZeneca underpaid hundreds of female and Hispanic sales reps, feds say esagonowsky Mon, 10/04/2021 - 16:17
Cáncer sin quimioterapia: una revolución silenciosa
Un número cada vez mayor de pacientes con cáncer, especialmente los de mama y pulmón, se libran del temido tratamiento en favor de otras alternativas.
Pfizer Booster Can Be Given After 6 Months, European Drug Agency Says
The E.U.’s main drug regulator also said that extra doses of the Moderna and Pfizer-BioNTech vaccines can be given to those with underlying health conditions as early as 28 days after the second dose.
Johnson & Johnson to Seek F.D.A. Authorization for Booster Shot
The request, expected this week, comes after a study found the company’s vaccine was only 71 percent effective against hospitalization from Covid-19.
La píldora contra la covid: así es como funciona
Las píldoras son eficaces y relativamente baratas, pero es poco probable que estén disponibles para todos los enfermos de covid.
Researchers retract preprint study that miscalculated higher heart inflammation risk for Moderna, Pfizer COVID vaccines
Researchers retract preprint study that miscalculated higher heart inflammation risk for Moderna, Pfizer COVID vaccines aliu Mon, 10/04/2021 - 10:54
Teva puts the brakes on troubled California sterile injectables plant: reports
Teva puts the brakes on troubled California sterile injectables plant: reports jkeenan Mon, 10/04/2021 - 10:51
Arcutis, with Amgen in its crosshairs, seeks FDA approval for topical psoriasis drug
Arcutis, with Amgen in its crosshairs, seeks FDA approval for topical psoriasis drug ntaylor Mon, 10/04/2021 - 10:10
Celltrion makes case for Remicade biobetter with subcut switch data
Celltrion makes case for Remicade biobetter with subcut switch data ntaylor Mon, 10/04/2021 - 10:05
After settling criminal price-fixing case, Novartis’ Sandoz inks $185M civil deal with feds
After settling criminal price-fixing case, Novartis' Sandoz inks $185M civil deal with feds kdunleavy Mon, 10/04/2021 - 09:39
Bayer recalls antifungal aerosol sprays on carcinogen contamination concerns
Bayer recalls antifungal aerosol sprays on carcinogen contamination concerns jkeenan Mon, 10/04/2021 - 09:25
Gilead’s Kite enters leukemia with Tecartus FDA approval, overlapping Novartis’ CAR-T rival Kymriah
Gilead's Kite enters leukemia with Tecartus FDA approval, overlapping Novartis' CAR-T rival Kymriah aliu Mon, 10/04/2021 - 09:23
Fauci: Americans Should Get Vaccinated Even if Merck’s Covid Pill Cuts Deaths
President Biden’s Covid adviser also says it is “too soon to tell” if the Delta surge will decline enough to allow safe gatherings around the holidays.
Racing rival Pfizer, Merck’s Vaxneuvance makes its case for an FDA approval in children
Racing rival Pfizer, Merck's Vaxneuvance makes its case for an FDA approval in children kdunleavy Sun, 10/03/2021 - 11:43
Merck Says Its Antiviral Pill Is Effective Against Covid
The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool against the virus.
Was the Decision on Boosters Bungled?
Readers discuss the government’s handling of the issue. Also: Abortion stories; criminal justice reform; voice recognition; extinct species.
Merck’s Covid Treatment Pill: What to Know About Molnupiravir
The pills are effective and relatively cheap, but they are unlikely to be available for everyone with Covid.
Judge denies Pfizer’s request to run 2 programs to subsidize patients for expensive heart drug
Judge denies Pfizer's request to run 2 programs to subsidize patients for expensive heart drug kdunleavy Fri, 10/01/2021 - 15:46